| Literature DB >> 33088318 |
Hamidreza Shetabi1, Seyed Jalal Hashemi1, Fariba Haghi2, Dariush Moradi Farsani1.
Abstract
BACKGROUND: The study was aimed to evaluate the safety and efficacy of fentanyl and pethidine on the sedative quality of patients who underwent phacoemulsification cataract surgery with Propofol.Entities:
Keywords: Cataract surgery; fentanyl; pethidine; propofol; sedation
Year: 2020 PMID: 33088318 PMCID: PMC7554428 DOI: 10.4103/jrms.JRMS_932_19
Source DB: PubMed Journal: J Res Med Sci ISSN: 1735-1995 Impact factor: 1.852
Figure 1Consort flow diagram of patients' recruitment
Demographic and basic characteristics of the patients in propofol-pethidine and propofol-fentanyl groups
| Variables | Propofol-pethidine ( | Propofol-fentanyl ( | |
|---|---|---|---|
| Age (years) | 67.55 (14.95) | 64.97 (8.74) | 0.391 |
| Sex (female/male) | 18 (51.4%)/17 (48.6%) | 20 (57.1%)/15 (43.9%) | 0.432 |
| ASA classification (I/II) | 6 (17.6%)/29 (82.4%) | 8 (22.9%)/27 (77.1%) | 0.591 |
| Weight (kg) | 69.77 (15.39) | 67.11 (11.65) | 0.418 |
| Height (cm) | 167.88 (8.96) | 166.54 (8.21) | 0.519 |
| BMI | 24.58 (4.11) | 24.19 (3.89) | 0.657 |
*Resulted from independent sample t-test and Chi-square test for continuous and categorical data. BMI=Body mass index; ASA=American Society of Anesthesiologists
Hemodynamic parameters of patients before, during and after procedure in in propofol-pethidine and propofol-fentanyl group
| Variable | Group | Time | Ptime effect | Pinteraction | Pintervention | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before intervention | During intervention | Recovery | ||||||||
| PR | PF | 73.41±9.80 | 70.15±11.98 | 68.53±12.21 | 70.26±12.38 | 68.35±12.27 | 67.15±11.43 | 0<0.001 | 0.23 | 0.08 |
| PP | 79.09±18.77 | 79.21±17.59 | 75.12±15.86 | 74.27±16.79 | 73.15±16.03 | 70.88±15.56 | 0<0.001 | |||
| 0.27 | 0.04 | 0.12 | 0.45 | 0.3 | 0.27 | |||||
| SBP | PF | 157.03±20.26 | 149.17±22.20 | 144.46±24.29 | 141.06±21.74 | 141.06±18.59 | 139.74±20.02 | 0<0.001 | 0.39 | 0.036 |
| PP | 144.53±20.17 | 143.41±18.03 | 138.44±17.34 | 135.38±18.51 | 133.38±16.21 | 129.12±15.33 | 0<0.001 | |||
| 0.01 | 0.28 | 0.28 | 0.30 | 0.07 | 0.01 | |||||
| DBP | PF | 90.40±12.33 | 86.66±11.71 | 83.74±12.98 | 83.54±12.28 | 83.11±12.49 | 81.89±12.57 | 0<0.001 | 0.73 | 0.07 |
| PP | 85.18±11.78 | 82.94±11.87 | 81.79±11.63 | 79.18±14.34 | 77.88±12.23 | 75.47±12.74 | 0<0.001 | |||
| 0.08 | 0.21 | 054 | 0.18 | 0.08 | 0.04 | |||||
| SPO2 | PF | 95.23±2.41 | 96.71±2.57 | 97.29±2.43 | 97.6±2.21 | 98.31±1.68 | 98.06±3.28 | 0<0.001 | 0.20 | 0.51 |
| PP | 95.73±1.81 | 97.55±1.87 | 97.42±2.46 | 97.65±2.24 | 97.85±1.97 | 98.48±1.62 | 0<0.001 | |||
| 0.34 | 0.17 | 0.69 | 0.80 | 0.29 | 0.49 | |||||
| MAP (mmHg) | PF | 110.37±16.62 | 107.88±13.76 | 103.91±17.16 | 104.56±15.98 | 103.03±18.63 | 99.53±18.02 | 0<0.001 | 0.77 | 0.07 |
| PP | 105.24±15.54 | 103.00±14.92 | 101.15±16.43 | 97.58±14.62 | 95.00±14.06 | 94.24±13.68 | 0<0.001 | |||
| 0.14 | 0.24 | 0.55 | 0.07 | 0.07 | 0.14 | |||||
P values resulted from repeated measures ANOVA and for SBP baseline value was considered as covariate and repeated measures ANCOVA was used. PP=Propofol-pethidine; PF=Propofol-fentanyl; PR=Pulse rate; SBP=Systolic blood pressure; DBP=Diastolic blood pressure; ETCO=End-tidal carbon dioxide; ANOVA=Analysis of variance
Figure 2Mean values of (a) systolic blood pressure, (b) diastolic blood pressure, (c) pulse rate, (d) SPO2 and (e) MAP during the study course in two study groups